What caused Figma's stock to drop in August?
Profit-taking after the IPO surge and concerns over valuation.
Finance / Stocks
Figma (FIG), a cloud software stock, experienced a volatile August 2025 after its initial public offering (IPO). After tripling on its IPO day, the stock pulled back, leading to investor uncertainty. This article examines the factors influe...
Figma's stock more than tripled on its opening day, climbing from an IPO price of $33 to a closing price of $115. It peaked at $142.92 before declining as early investors took profits. Trading volume decreased throughout August as the stock stabilized.
Analysts' views on Figma varied. Piper Sandler rated it 'overweight' with an $85 price target, citing its unique platform and business model. Goldman Sachs expressed concern about visibility into Figma's momentum and revenue growth.
Figma is expected to release its first earnings report as a public company. The consensus estimate is $248.7 million in revenue, a 40.3% increase year-over-year, and earnings per share of $0.08.
Profit-taking after the IPO surge and concerns over valuation.
Figma's price-to-sales ratio is 36, which is considered expensive.
Analysts expect revenue of $248.7 million and earnings per share of $0.08.
Do you think Figma will maintain its growth trajectory? Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.